A61K47/00
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
A61K47/00
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
A61K47/50
the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
A61K47/50
the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
A61K47/51
the non-active ingredient being a modifying agent
A61K47/51
the non-active ingredient being a modifying agent
A61K47/68
the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
A61K47/68
the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
A61K47/6801
Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
A61K47/6801
Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
A61K47/6803
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
A61K47/6803
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
A61K47/6807
the drug or compound being a sugar, nucleoside, nucleotide, nucleic acid, e.g. RNA antisense
A61K47/6807
the drug or compound being a sugar, nucleoside, nucleotide, nucleic acid, e.g. RNA antisense